NZ 602479 Disclosed is a pharmaceutical composition for ophthalmic administration, which comprises recombinant human serum albumin produced by a recombinant yeast obtained by transforming a yeast with a gene for human serum albumin in an amount of about 1-100 w/v%. Also disclosed is the use of said pharmaceutical composition for the treatment of dry eye.